“Efficacy and Tolerability of Valganciclovir 6 Months Vs 6 Weeks in Symptomatic Cytomegalovirus Infection in Infants: An Open Level Randomized Controlled Trial”. European Journal of Clinical Medicine 3, no. 1 (January 11, 2022): 18–25. Accessed October 11, 2025. https://ej-clinicmed.org/index.php/clinicmed/article/view/122.